 The registry is a prospective, multicenter, single arm post-market real-world registry in the U.S. assessing the clinical use, safety and outcomes of the Lutonix 035 DCB Catheter in the Superficial Femoral Artery SFA and Popliteal Arteries PA. Registry subjects will be followed for up to three years post-index procedure. 